Blume Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,000
| Closed | – | – | 236 |
|
|
2020
Q2 | $0 | Hold |
1,000
| – | – | ﹤0.01% | 248 |
|
|
2020
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 198 |
|
|
2019
Q4 | $23K | Hold |
1,000
| – | – | 0.01% | 156 |
|
|
2019
Q3 | $26K | Hold |
1,000
| – | – | 0.01% | 153 |
|
|
2019
Q2 | $27K | Hold |
1,000
| – | – | 0.01% | 144 |
|
|
2019
Q1 | $35K | Hold |
1,000
| – | – | 0.02% | 143 |
|
|
2018
Q4 | $20K | Hold |
1,000
| – | – | 0.01% | 162 |
|
|
2018
Q3 | $27K | Hold |
1,000
| – | – | 0.01% | 140 |
|
|
2018
Q2 | $38K | Hold |
1,000
| – | – | 0.02% | 126 |
|
|
2018
Q1 | $32K | Hold |
1,000
| – | – | 0.02% | 140 |
|
|
2017
Q4 | $49K | Hold |
1,000
| – | – | 0.03% | 123 |
|
|
2017
Q3 | $54K | Hold |
1,000
| – | – | 0.03% | 116 |
|
|
2017
Q2 | $56K | Hold |
1,000
| – | – | 0.03% | 97 |
|
|
2017
Q1 | $39K | Hold |
1,000
| – | – | 0.02% | 114 |
|
|
2016
Q4 | $22K | Hold |
1,000
| – | – | 0.01% | 134 |
|
|
2016
Q3 | $23K | Hold |
1,000
| – | – | 0.01% | 124 |
|
|
2016
Q2 | $24K | Hold |
1,000
| – | – | 0.02% | 135 |
|
|
2016
Q1 | $20K | Hold |
1,000
| – | – | 0.01% | 145 |
|
|
2015
Q4 | $51K | Hold |
1,000
| – | – | 0.04% | 101 |
|
|
2015
Q3 | $43K | Hold |
1,000
| – | – | 0.03% | 105 |
|
|
2015
Q2 | $46K | Hold |
1,000
| – | – | 0.03% | 117 |
|
|
2015
Q1 | $38K | Hold |
1,000
| – | – | 0.03% | 149 |
|
|
2014
Q4 | $28K | Hold |
1,000
| – | – | 0.02% | 177 |
|
|
2014
Q3 | $25K | Hold |
1,000
| – | – | 0.02% | 129 |
|
|
2014
Q2 | $29K | Hold |
1,000
| – | – | 0.02% | 126 |
|
|
2014
Q1 | $26K | Hold |
1,000
| – | – | 0.02% | 143 |
|
|
2013
Q4 | $26K | Buy |
+1,000
| New | +$24.3K | 0.02% | 162 |
|
Blume Capital Management's PTLA Position: Q3 2020 in Review
Blume Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 1,000 shares.
Blume Capital Management first reported a position in PTLA in Q4 2013 and held it in 27 quarters. The position peaked at $56K in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Blume Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Blume Capital Management sold 1,000 Portola Pharmaceuticals, Inc. shares in Q3 2020.
- Blume Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q4 2013 and held it in 27 quarters.
- Blume Capital Management's Portola Pharmaceuticals, Inc. position peaked at $56K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Blume Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.